Salarius Pharmaceuticals to Report Second Quarter 2021 Financial Results Back Salarius Pharmaceuticals to Report Second Quarter 2021 Financial Results Read More
Salarius Pharmaceuticals Announces Aundrietta Duncan, Ph.D., To Present During Virtual Epigenetic Therapeutic Targets Summit Back Salarius Pharmaceuticals Announces Aundrietta Duncan, Ph.D., To Present During Virtual Epigenetic Therapeutic Targets Summit Read More
Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas Back Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas Read More
Salarius Pharmaceuticals to Present at the Virtual Ladenburg Thalmann Healthcare Conference Back Salarius Pharmaceuticals to Present at the Virtual Ladenburg Thalmann Healthcare Conference Read More